A major breakthrough in cancer study is emerging with the use of mini-antibodies to re-engage dysfunctional p53. This crucial malignant suppressor protein is frequently disabled in many types of tumors, causing https://dirstop.com/story29807481/mini-antibodies-revive-p53-a-potential-pathway-for-malignant-treatment